Skip to content
10-Q

Quarterly Report

WEST PHARMACEUTICAL SERVICES INC WST

0000105770-25-000093

← back to feed
Filed
Oct 23, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 20, 2025 71.94M sh
Shares Diluted Q3 2025 · Sep 30, 2025 72.6M sh
Shares Diluted Q3 2025 · Sep 30, 2025 72.7M sh
Shares Diluted Q3 2025 · Sep 30, 2024 73.4M sh
Shares Diluted Q3 2025 · Sep 30, 2024 73.8M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $134M
Stock Repurchased Q3 2025 · Sep 30, 2024 $506.5M
Dividends Paid Q3 2025 · Sep 30, 2025 $45.4M
Dividends Paid Q3 2025 · Sep 30, 2024 $43.8M
Capex Q3 2025 · Sep 30, 2025 $209.8M
Capex Q3 2025 · Sep 30, 2024 $272.1M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $503.7M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $463.3M
Long Term Debt Q3 2025 · Sep 30, 2025 $202.7M
Long Term Debt Q3 2025 · Dec 31, 2024 $202.6M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $628.5M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $484.6M
Stockholders Equity Q3 2025 · Sep 30, 2025 $3.05B
Stockholders Equity Q3 2025 · Jun 30, 2025 $2.93B
Stockholders Equity Q3 2025 · Mar 31, 2025 $2.68B
Stockholders Equity Q3 2025 · Dec 31, 2024 $2.68B
Stockholders Equity Q3 2025 · Sep 30, 2024 $2.75B
Stockholders Equity Q3 2025 · Jun 30, 2024 $2.58B
Stockholders Equity Q3 2025 · Mar 31, 2024 $2.68B
Stockholders Equity Q3 2025 · Dec 31, 2023 $2.88B
Current Liabilities Q3 2025 · Sep 30, 2025 $635.4M
Current Liabilities Q3 2025 · Dec 31, 2024 $550.4M
Total Liabilities Q3 2025 · Sep 30, 2025 $1.05B
Total Liabilities Q3 2025 · Dec 31, 2024 $961.1M
Current Assets Q3 2025 · Sep 30, 2025 $1.82B
Current Assets Q3 2025 · Dec 31, 2024 $1.54B
Total Assets Q3 2025 · Sep 30, 2025 $4.11B
Total Assets Q3 2025 · Dec 31, 2024 $3.64B
Eps Diluted Q3 2025 · Sep 30, 2025 $1.92
Eps Diluted Q3 2025 · Sep 30, 2025 $4.97
Eps Diluted Q3 2025 · Sep 30, 2024 $1.85
Eps Diluted Q3 2025 · Sep 30, 2024 $4.91
Eps Basic Q3 2025 · Sep 30, 2025 $1.94
Eps Basic Q3 2025 · Sep 30, 2025 $5.00
Eps Basic Q3 2025 · Sep 30, 2024 $1.87
Eps Basic Q3 2025 · Sep 30, 2024 $4.96
Sga Expense Q3 2025 · Sep 30, 2025 $102.7M
Sga Expense Q3 2025 · Sep 30, 2025 $286.6M
Sga Expense Q3 2025 · Sep 30, 2024 $83.5M
Sga Expense Q3 2025 · Sep 30, 2024 $253.2M
Rd Expense Q3 2025 · Sep 30, 2025 $17.1M
Rd Expense Q3 2025 · Sep 30, 2025 $52.5M
Rd Expense Q3 2025 · Sep 30, 2024 $15.5M
Rd Expense Q3 2025 · Sep 30, 2024 $50.6M
Net Income Q3 2025 · Sep 30, 2025 $140M
Net Income Q3 2025 · Sep 30, 2025 $361.6M
Net Income Q3 2025 · Jun 30, 2025 $131.8M
Net Income Q3 2025 · Mar 31, 2025 $89.8M
Net Income Q3 2025 · Sep 30, 2024 $136M
Net Income Q3 2025 · Sep 30, 2024 $362.6M
Net Income Q3 2025 · Jun 30, 2024 $111.3M
Net Income Q3 2025 · Mar 31, 2024 $115.3M
Operating Income Q3 2025 · Sep 30, 2025 $167.6M
Operating Income Q3 2025 · Sep 30, 2025 $428.3M
Operating Income Q3 2025 · Sep 30, 2024 $161.3M
Operating Income Q3 2025 · Sep 30, 2024 $410.3M
Gross Profit Q3 2025 · Sep 30, 2025 $294.3M
Gross Profit Q3 2025 · Sep 30, 2025 $800.1M
Gross Profit Q3 2025 · Sep 30, 2024 $264.7M
Gross Profit Q3 2025 · Sep 30, 2024 $724.9M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $510.3M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $1.47B
Cost Of Revenue Q3 2025 · Sep 30, 2024 $482.2M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $1.42B
Revenue Q3 2025 · Sep 30, 2025 $804.6M
Revenue Q3 2025 · Sep 30, 2025 $2.27B
Revenue Q3 2025 · Sep 30, 2024 $746.9M
Revenue Q3 2025 · Sep 30, 2024 $2.14B